The government has published its National Cancer Plan, outlining how it intends to transform cancer care and outcomes in England by 2035. The plan aims for patients to receive faster diagnosis, ...

Although not a household scientific name like Albert Einstein or Isaac Newton, Indian mathematician Srinivasa Ramanujan—who tragically died in 1920 at the age of 32—was one of the greatest minds in ...

Elizabeth Guevara is a personal finance reporter who explains the world of business and economics and how it impacts your finances. She joined Investopedia in 2024. Investopedia / Photo Composite by ...

In at least one respect, all time loop stories repeat themselves endlessly. The protagonists — Bill Murray in “Groundhog Day,” Tom Cruise in “Edge of Tomorrow,” Andy Samberg in “Palm Springs” — start ...

The Danish author Solvej Balle’s experimental opus reframes the tedium of contemporary life as a source of unexpected wonders. Solvej Balle in her garden in Denmark.Credit...Giulia Mangione for The ...

With drugmakers freezing investment in the U.K., the Association of the British Pharmaceutical Industry (ABPI) has set out its vision for how Scotland can buck the trend and become a leader in R&D and ...

LONDON, Sept 10 (Reuters) - Britain's main pharmaceutical lobby group said on Wednesday foreign investment in the sector has fallen due to its approach to drug pricing, as the industry remains locked ...

The U.K. is losing business opportunities in the life sciences sector because the government undervalues the economic and social benefits of investing in the manufacturing of innovative medicines, ...

The prevailing narrative regarding the role that generative AI can play in the life of a CPA goes something like this: Emerging AI tools can take care of busy work, freeing professionals to spend more ...

HELOCs, or home equity lines of credit, give homeowners a way to leverage the growing value of their house for anything from renovations to college tuition — and enjoy 10 years of interest-only ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...